Seeking Alpha

Catalyst Pharmaceuticals (CPRX) pops 10% at the open, apparently sparked by a positive Seeking...

Catalyst Pharmaceuticals (CPRX) pops 10% at the open, apparently sparked by a positive Seeking Alpha article highlighting upcoming Phase 2 data on its drug for treatment of addiction to cocaine and other addictive substances. Author Scott Matusow thinks CPRX could gap up similar to THLD, VRTX and SRPT after their recent data results.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|